Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants
Verastem, Inc.
Verastem, Inc.
Baylor College of Medicine
Colotech A/S
GI View Ltd.
Universitätsklinikum Hamburg-Eppendorf
Texas Tech University Health Sciences Center, El Paso
Assistance Publique - HĂ´pitaux de Paris
Assistance Publique - HĂ´pitaux de Paris